Elsevier

Biological Psychiatry

Volume 49, Issue 5, 1 March 2001, Pages 391-404
Biological Psychiatry

Review
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

https://doi.org/10.1016/S0006-3223(00)01088-XGet rights and content

Abstract

%Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis has been reliably observed in patients with major depression. One of the primary features of this HPA axis hyperactivity is reduced sensitivity to the inhibitory effects of the glucocorticoid dexamethasone on the production of adrenocorticotropic hormone and cortisol during the dexamethasone suppression test and, more recently, the dexamethasone–corticotropin-releasing hormone test. Because the effects of glucocorticoids are mediated by intracellular receptors including, most notably, the glucocorticoid receptor (GR), a number of studies have considered the possibility that the number and/or function of GRs are reduced in depressed patients. Moreover, whether antidepressants act by reversing these putative GR changes has been examined. The extant literature on GR receptors in major depression was reviewed along with studies examining the impact of antidepressants on the GR. The data support the hypothesis that the function of the GR is reduced in major depression in the absence of clear evidence of decreased GR expression. The data also indicate that some antidepressants have direct effects on the GR, leading to enhanced GR function and increased GR expression. Hypotheses regarding the mechanism of these receptor changes involve relevant second messenger pathways that regulate GR function. The findings indicate that the GR is an important molecular target in major depression. Further elucidation of the biochemical and molecular mechanisms involved in GR changes in major depression is an exciting frontier that will no doubt lead to new insights into the pathophysiology and treatment of affective disorders.

Introduction

Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis in patients with major depression is one of the most consistent findings in biological psychiatry. Specifically, patients with major depression have been shown to exhibit increased concentrations of cortisol in plasma, urine, and cerebrospinal fluid (CSF); an exaggerated cortisol response to adrenocorticotropic hormone (ACTH); and an enlargement of both the pituitary and the adrenal glands Gold et al 1988, Holsboer and Barden 1996, Nemeroff 1996, Owens and Nemeroff 1993.

These HPA axis alterations are believed to be secondary to hypersecretion of corticotropin-releasing hormone (CRH), which has behavioral effects in animals that are similar to those seen in depressed patients, including alterations in activity, appetite, and sleep (Owens and Nemeroff 1993). Moreover, depressed patients exhibit increased concentrations of CRH in the CSF, increased CRH messenger RNA (mRNA) and protein in the paraventricular nucleus (PVN) of the hypothalamus (postmortem samples), and a blunted ACTH response to a CRH challenge (likely reflecting downregulation of pituitary CRH receptors) Gold et al 1988, Nemeroff 1996. Finally, downregulation of CRH receptors in the frontal cortex of victims of suicide (many of whom were presumably depressed) has been described (Nemeroff 1996).

Although the mechanism by which extrahypothalamic CRH is elevated in depression has not been resolved, the increased levels of CRH in the hypothalamus are thought to be related, in part, to altered feedback inhibition by endogenous glucocorticoids. Through binding to their receptors in HPA axis tissues, endogenous glucocorticoids serve as potent negative regulators of HPA axis activity including the synthesis and release of CRH in the PVN Owens and Nemeroff 1993, Reul and de Kloet 1985. Data supporting the notion that glucocorticoid-mediated feedback inhibition is impaired in major depression come from a multitude of studies demonstrating nonsuppression of cortisol secretion following administration of the synthetic glucocorticoid dexamethasone and more recent studies showing a lack of inhibition of ACTH responses to CRH following dexamethasone pretreatment Gold et al 1988, Heuser et al 1994, Holsboer and Barden 1996, Nemeroff 1996, Owens and Nemeroff 1993. Although nonsuppression to dexamethasone in the dexamethasone suppression test (DST) and the dexamethasone–CRH test likely represent impaired feedback inhibition at the level of the pituitary de Kloet 1998, Miller et al 1992, impaired responsiveness to hydrocortisone challenge in depressed patients suggests these feedback alterations also occur in the brain (Young et al 1991). Furthermore, the existence of reduced HPA axis suppression by dexamethasone in first-degree relatives of depressed individuals suggests that altered feedback inhibition may represent a genetic (trait) vulnerability to the depressive disorders (Modell et al 1998).

Feedback regulation of the HPA axis by glucocorticoids is mediated through two distinct intracellular receptor subtypes referred to as the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR) (Reul and de Kloet, 1985). The MR has a high affinity for endogenous corticosteroids and is believed to play a role in the regulation of circadian fluctuations in these hormones (especially the regulation of ACTH secretion during the diurnal trough in cortisol secretion). In contrast to the MR, the GR has a high affinity for dexamethasone and a lower affinity for endogenous corticosteroids. The GR is therefore believed to be more important in the regulation of the response to stress when endogenous levels of glucocorticoids are high. Recently, Spencer et al (1998) and de Kloet et al (1998) have clarified that GR activation is necessary for the HPA feedback regulation when levels of glucocorticoids are high (response to stress, circadian peak), but that the MR also plays an important role by modulating GR-dependent regulation. Because patients with major depression exhibit impaired HPA negative feedback in the context of elevated circulating levels of cortisol and because altered HPA axis responsiveness has been characterized with dexamethasone, which selectively binds GR in vivo, studies investigating corticosteroid receptors in major depression have logically focused on the expression and function of GR.

Section snippets

Glucocorticoid receptors in depression

Over the past 15 years a number of studies have assessed GRs in patients with major depression. In general, these studies have measured GR numbers directly or have examined the in vitro or in vivo influence of glucocorticoids on functions known to be regulated by the GR. These GR assessments have been made primarily on peripheral cell types including immune cells (mononuclear and polymorphonuclear leukocytes) and fibroblasts (gingival and skin). Limited information exists regarding the number

Mechanisms of glucocorticoid receptor resistance

Three major possibilities have been considered regarding the mechanism(s) of GR resistance in depression. These include: 1) GR downregulation secondary to persistent hypercortisolism, 2) a primary alteration in the genetic structure of the GR, and 3) a decrease in GR function secondary to alterations in ligand-independent pathways that regulate the GR (Bamberger et al 1996).

As previously discussed, the cytosolic and whole cell GR binding data do not provide a compelling case for GR

Impact of antidepressants on glucocorticoid receptor number and function

Perhaps the most striking support of the hypothesis that abnormalities in the GR contribute to the pathophysiology of major depression derives from studies suggesting that antidepressants may exert their clinical effects through direct modulation of the GR.

A number of animal studies have examined the impact of long-term in vivo treatment with tricyclic and nontricyclic antidepressants or electroconvulsive therapy on GR expression and glucocorticoid feedback inhibition Table 3, Table 4. These

Conclusions

Given the importance of glucocorticoids and the GR in the regulation of the HPA axis, it is logical to hypothesize that disruption of glucocorticoid action through altered functioning of the GR may be involved in the pathophysiology of major depression, a disorder that is characterized by HPA axis hyperactivity and CRH hypersecretion. Glucocorticoid resistance in depressed patients provides evidence of GR dysfunction, and data demonstrating GR regulation by steroid-independent factors that are

Acknowledgements

CMP is a United Kingdom Medical Research Council Clinical Training Fellow. This work was also supported by grants from the National Institute of Mental Health (Nos. MH00680 and MH47674) and the National Alliance for Research on Schizophrenia and Depression (van Ameringen Investigator) (AHM).

The authors thank Andrea Reemsnyder for her assistance with manuscript preparation.

References (98)

  • J.F Lopez et al.

    Regulation of serotonin 1A, glucocorticoid and mineralocorticoid receptor in rat and human hippocampusImplications for the neurobiology of depression

    Biol Psychiatry

    (1998)
  • M.T Lowy et al.

    Comparison of in vivo and in vitro glucocorticoid sensitivity in depressionRelationship to the dexamethasone suppression test

    Biol Psychiatry

    (1988)
  • M Maes et al.

    Relationship between interleukin-6 activity, acute phase proteins, and the function of the hypothalamic-pituitary-adrenal axis in severe depression

    Psychiatry Res

    (1993)
  • T.M Maguire et al.

    Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA function

    Biol Psychiatry

    (1997)
  • A.H Miller et al.

    Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system

    Cell Immunol

    (1998)
  • A.H Miller et al.

    Adrenal steroid receptor activation in rat brain and pituitary following dexamethasoneImplications for the dexamethasone suppression test

    Biol Psychiatry

    (1992)
  • B.W O’Malley et al.

    An alternative ligand-independent pathway for activation of steroid receptors

    Recent Prog Horm Res

    (1995)
  • A Peiffer et al.

    Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain

    Psychoneuroendocrinology

    (1991)
  • W.B Pratt

    The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor

    J Biol Chem

    (1993)
  • E Przegalinski et al.

    The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats

    Neuropharmacology

    (1993)
  • R Rupprecht et al.

    Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone

    Biol Psychiatry

    (1991)
  • R Rupprecht et al.

    Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery

    J Affect Disord

    (1991)
  • E.R Sanchez

    Heat shock induces translocation of the unliganded glucocorticoid receptor

    J Biol Chem

    (1992)
  • L.C Scherrer et al.

    Structural and functional reconstitution of the glucocorticoid receptor-hsp90 complex

    J Biol Chem

    (1990)
  • J.A Schlechte et al.

    Lymphocyte glucocorticoid receptor binding in depressed patients with hypercortisolemia

    Psychoneuroendocrinology

    (1985)
  • R.L Spencer et al.

    Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue

    Brain Res

    (1991)
  • J.H Thakore et al.

    Increased intra-abdominal fat deposition in patients with major depression illness as measured by computed tomography

    Biol Psychiatry

    (1997)
  • H Vedder et al.

    Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone

    J Psychiatr Res

    (1999)
  • A Wassef et al.

    Glucocorticoid receptor binding in three different cell types in major depressive disorderLack of evidence of receptor binding defect

    Prog Neuropsychopharmacol Biol Psychiatry

    (1992)
  • A Wassef et al.

    Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression

    Psychoneuroendocrinology

    (1990)
  • M.J Webster et al.

    Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia

    Schizophr Res

    (2000)
  • N Wodarz et al.

    Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression

    J Affect Disord

    (1991)
  • N Wodarz et al.

    Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder

    J Affect Disord

    (1992)
  • J.L.W Yau et al.

    Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatmentRelationship with spatial learning in young and aged rats

    Psychoneuroendocrinology

    (1995)
  • R Yehuda et al.

    Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders

    Biol Psychiatry

    (1993)
  • E.A Young et al.

    Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures

    Psychoneuroendocrinology

    (1990)
  • S Avissar et al.

    Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression

    Am J Psychiatry

    (1997)
  • C.M Bamberger et al.

    Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

    Endocr Rev

    (1996)
  • L.S Brady et al.

    Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain

    J Clin Invest

    (1991)
  • B Budziszewska et al.

    Antidepressant drugs inhibit glucocorticoid receptor mediated gene transcription—a possible mechanism

    Br J Pharmacol

    (2000)
  • B Budziszewska et al.

    The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus

    Pol J Pharmacol

    (1994)
  • J Chen et al.

    Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content

    J Pharmacol Exp Ther

    (1995)
  • J Chen et al.

    Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase

    J Neurochem

    (1995)
  • E.R de Kloet et al.

    Brain corticosteroid receptor balance in health and disease

    Endocr Rev

    (1998)
  • R.R Denton et al.

    Differential autoregulation of glucocorticoid receptor expression in human T- and B-cell lines

    Endocrinology

    (1993)
  • M Deuschle et al.

    Pulse-dosing and conventional application of doxepinEffects on psychopathology and hypothalamus-pituitary-adrenal axis

    J Clin Psychopharmacol

    (1997)
  • G.E Duncan et al.

    Differential effects of chronic antidepressant treatment on swim stress and fluoxetine induced secretion of corticosterone and progesterone

    J Pharmacol Exp Ther

    (1998)
  • A Eiring et al.

    Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA

    J Neural Transm

    (1997)
  • Gold PW, Goodwin FK, Chrousos GP (1988): Clinical and biochemical manifestation of depression. Relation to the...
  • Cited by (986)

    View all citing articles on Scopus
    View full text